Drugs, Key Data 2013
OFDT, 8 p.
The purpose of this publication is to periodically collect the most recent and most relevant key quantitative indicators of drug use, whether illegal substances, tobacco, alcohol or psychotropic medicines. These data constitute a common foundation of knowledge on which public authority actions are based, coordinated by the French Interministerial Mission for the Fight against Drugs and Drug Addiction (MILDT) placed under the authority of the Prime Minister.
This document, prepared by the French Monitoring Centre for Drugs and Drug Addiction (OFDT), relies on its own research as well as the work of other institutions. First and foremost, it summarises for the main substances the levels of use observed in the French population as a whole. Then, it provides detailed information on use, treatment, health and social consequences as well as trafficking data per product. When possible, trends in these areas are provided.
Drugs in Europe
How is the COVID-19 pandemic affecting drug use, supply and services?
Drug use and harms
What are the health costs of drug use in Europe today?
What do the latest data tell us about drug production and trafficking trends?
These and other questions are explored in the 2021 European Drug Report, our annual overview of the drug situation in Europe.
The annual Statistical Bulletin contains the most recent available data on the drug situation in Europe provided by the Member States. These datasets underpin the analysis presented in the European Drug Report. All data may be viewed interactively on screen and downloaded in Excel format..
The European Union and the drug phenomenon
The European Union & the drug phenomenon : Frequently asked questions, joint publication between the EMCDDA and the European Commission, october 2010, 12 p.